Mivacurium
General information:
| Withdrawn ID: | 679 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | M03AC10 |
| Molecular Formula: | C58H80N2O14 |
| Molweight: | 1029.26 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1992 |
| First withdrawn: | 2007 |
| Last withdrawn: | 2007 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Mivacurium as primary suspect: | 27 |
|---|
Reported final outcomes:
| Death: | 10 |
|---|---|
| Intervention required to prevent permanent impairment/damage: | 10 |
| Hospitalization (initial or prolonged): | 4 |
| Life-Threatening condition: | 2 |
Reported side-effects:
| Side-effect | Case number |
|---|---|
| DEATH | 10 |
| DRUG EFFECT PROLONGED | 6 |
| NEUROMUSCULAR BLOCK PROLONGED | 5 |
| ANAPHYLACTIC REACTION | 2 |
| ANAESTHETIC COMPLICATION NEUROLOGICAL | 2 |
| Tachycardia | 1 |
| Rales | 1 |
| PSEUDOCHOLINESTERASE DEFICIENCY | 1 |
| MEDICATION ERROR | 1 |
| Erythema | 1 |
| Dyspnoea | 1 |
| Drug hypersensitivity | 1 |
| Anaphylactic shock | 1 |
Toxicity information:
| Toxicity class: | 4 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 2000 mg/kg |
External links:
| ChEBML: | CHEMBL1182833 |
|---|---|
| DrugBank: | DB01226 |